Certain COVID-19 vaccine developers that the Trump administration left out of the final round of Operation Warp Speed are under pressure on the loss of potential federal funding to support their development efforts.
Selected tickers: Vir Biotechnology (VIR -9.5%), Novavax (NVAX -13.6%), Dynavax (DVAX -4.4%), Altimmune (ALT -6.6%), BioNTech (BNTX -1.0%), Arcturus Therapeutics (ARCT -11.6%), Soligenix (SNGX), GeoVax Labs (OTCPK:GOVX -3.9%), Inovio Pharmaceuticals (INO -12.8%), iBio (IBIO -5.2%), Vaxart (VXRT -6.3%)
https://seekingalpha.com/news/3580197-non-warp-speed-covidminus-19-vaccine-players-under-pressure
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.